080720 — Union Korea Pharm Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro Cap

Annual income statement for Union Korea Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	48,304	61,293	63,169	51,280	36,378
Cost of Revenue
Gross Profit	15,239	24,019	20,897	14,231	7,831
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	59,452	59,994	75,380	73,760	59,763
Operating Profit	-11,148	1,300	-12,211	-22,480	-23,385
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-14,477	944	-14,404	-18,972	-27,806
Provision for Income Taxes
Net Income After Taxes	-11,109	-932	-18,156	-20,916	-30,820
Net Income Before Extraordinary Items
Net Income	-11,109	-932	-18,156	-20,916	-30,820
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-11,109	-932	-18,156	-20,916	-30,820
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-1,386	-129	-1,898	-2,086	-3,713
Dividends per Share